Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
2,3-Dihydro-1,4-benzodioxin-5-ol → 3-cyclohexyl-2-[4-(2,3-dihydro-benzo[1,4]dioxin-5-yloxy)-6-oxo-6H-pyridazin-1-yl]-propionic acid
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 2,3-Dihydro-1,4-benzodioxin-5-ol | HCID 82520 | — |
| 반응물 | 4,5-Dichloro-2-(tetrahydro-pyran-2-yl)-2H-pyridazin-3-one | HCID 10729262 | — |
| 반응물 | 2-Bromo-3-cyclohexyl-propionic acid methyl ester | HCID 57919170 | — |
| 생성물 | 3-cyclohexyl-2-[4-(2,3-dihydro-benzo[1,4]dioxin-5-yloxy)-6-oxo-6H-pyridazin-1-yl]-propionic acid | HCID 57919253 | — |
반응 단계
In an analogous manner to the stepwise sequence outlined in Intermediate 19, starting from 4,5-dichloro-2-(tetrahydropyran-2-yl)-2H-pyridazin-3-one (Intermediate 20) and 2,3-dihydro-benzo[1,4]dioxin-5-ol and alkylating with 2-bromo-3-cyclohexyl-propionic acid methyl ester (Intermediate 12) afforded 3-cyclohexyl-2-[4-(2,3-dihydro-benzo[1,4]dioxin-5-yloxy)-6-oxo-6H-pyridazin-1-yl]-propionic acid (30 mg, 89% for the final step) which was used in Example 133.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08258134B2 |
| 출처 데이터셋 | uspto-grants-2012_09 |
| ORD ID | ord-74b14fa0247e4bbaa03e500ba47bbc91 |
| 출처 메모 | uspto-grants-2012_09 |